Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-24-044532
Filing Date
2024-11-12
Accepted
2024-11-12 08:00:53
Documents
100
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 37135
2 ex99-1.htm EX-99.1 414616
3 ex99-2.htm   iXBRL EX-99.2 1720576
4 ex99-3.htm EX-99.3 21664
5 ex99-4.htm EX-99.4 21598
6 ex99-1_001.jpg GRAPHIC 3854
7 ex99-1_002.jpg GRAPHIC 199749
8 ex99-1_003.jpg GRAPHIC 107641
9 ex99-2_001.jpg GRAPHIC 10085
  Complete submission text file 0001493152-24-044532.txt   10383320

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE csci-20240930.xsd EX-101.SCH 78287
11 XBRL CALCULATION FILE csci-20240930_cal.xml EX-101.CAL 85804
12 XBRL DEFINITION FILE csci-20240930_def.xml EX-101.DEF 210276
13 XBRL LABEL FILE csci-20240930_lab.xml EX-101.LAB 498919
14 XBRL PRESENTATION FILE csci-20240930_pre.xml EX-101.PRE 390870
102 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 2352436
Mailing Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7
Business Address C/O NORTON ROSE FULBRIGHT CANADA LLP 222 BAY STREET, SUITE 3000, PO BOX 53 TORONTO A6 M5K 1E7 843-900-3201
COSCIENS Biopharma Inc. (Filer) CIK: 0001113423 (see all company filings)

EIN.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 241443501
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)